<http://schema.org/description>
"The proposed dosing regimen for afrequent nightly urination treatment, developed by Allergan Plc and privately held Serenity Pharmaceuticals, has notbeen adequately studied in clinical trials, a preliminary reviewby the U.S. Food and Drug Administration staff concluded."^^<http://www.w3.org/2001/XMLSchema#string>
<http://cn.reuters.com/article/allergan-fda-urology-idCNL1N1CK15L>